Colorectal Cancer
A022004
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
EA2201 (JIT) (Suspended)
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Advanced Rectal Cancer( Suspended)
GI008
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
NRG-GI005 (Suspended)
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery (Suspended)
NSABP C-14
CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
RAIN-3202 (JIT)
Milademetan in Advanced/​Metastatic Solid Tumors
S1820
Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors
S2107
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
WF-1806
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
